SCHEMBL13348170

SCHEMBL13348170

CCC(=O)N1CCc2cccc(COc3ccc(CCC=O)c(F)c3)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 2/20 0.39
PTGER2 P43116 2/20 0.39
FFAR1 O14842 2/20 0.35
MAPT P10636 5/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
POLB P06746 1/20 0.35
MAOA P21397 3/20 0.35
MAOB P27338 3/20 0.35
FFAR4 Q5NUL3 1/20 0.35
CD274 Q9NZQ7 2/20 0.35
PDCD1 Q15116 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
PARP14 Q460N5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13348045 0.89 DRD2 (0.39) PTGER4PTGER2FFAR1MAPTRAB9A
SCHEMBL13312434 0.88 FFAR1 (0.48) PTGER4PTGER2FFAR1FFAR4
SCHEMBL13348179 0.86 PTGER4 (0.43) PTGER4PTGER2FFAR1SMN1; SMN2RAB9A
SCHEMBL13348407 0.85 FFAR1 (0.38) PTGER4PTGER2FFAR1MAOAMAOB
SCHEMBL13348134 0.85 SCN3A (0.34) PTGER4PTGER2FFAR1MAPTSMN1; SMN2
SCHEMBL13348240 0.84 PTGER2 (0.49) PTGER4PTGER2MAPTSMN1; SMN2RAB9A
SCHEMBL13348283 0.84 ALDH1A1 (0.46) PTGER4PTGER2ALDH1A1PARP14PARP10
SCHEMBL13348239 0.83 PTGER4 (0.37) PTGER4PTGER2FFAR1MAOAMAOB
SCHEMBL13348138 0.81 HPD (0.41) PTGER4PTGER2MAPTSMN1; SMN2NPC1
SCHEMBL13348108 0.80 AOC3 (0.38) PTGER4PTGER2FFAR1MAOBCD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES ASTELLAS PHARMA INC. (JP) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES GPR119, GPR65, HCAR1 PTGER4 1432/4885PTGER2 3346/4885FFAR1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.